Metraipolis › archive › dc_7b1acfa27303

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune… — Europe PMC PMID:42440530

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440530
DOI
10.3389/fimmu.2026.1866067
License (as archived)
solo-consultazione
Archived
2026-10-08T00:35:34.215Z
SHA-256 of the archived text
5af0c37a24d729edf525ff6a8e77052549c8688d22d9b32a71fb993f4ffebc01
Stable URL of this page
https://metraipolis.com/documento/dc_7b1acfa27303

How to cite

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune… — Europe PMC PMID:42440530 — Europe PMC (en), https://europepmc.org/article/MED/42440530 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b1acfa27303 (Metraipolis archive dc_7b1acfa27303, sha256 5af0c37a24d729edf525ff6a8e77052549c8688d22d9b32a71fb993f4ffebc01)
BibTeX
@misc{dc7b1acfa27303,
  title = {The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune… — Europe PMC PMID:42440530},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440530},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b1acfa27303; sha256 5af0c37a24d729edf525ff6a8e77052549c8688d22d9b32a71fb993f4ffebc01},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440530. Agents can read the archived copy with the MCP tool read_document.